Delivery Order SPE2DR25D3004-SPE2DR26FXPF4
- Not listed
- The Defense Logistics Agency awarded a $1,033.08 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count). This competitively awarded, firm fixed-price contract is scheduled for completion by December 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,851.36 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a 90-count quantity. This competitively awarded, firm fixed-price contract is categorized as a delivery order with an ultimate completion date of September 17, 2025, and carries no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $6,361.13 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets in a quantity of 90 units. This competitive award, issued on October 29, 2025, with an ultimate completion date of October 30, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $3,671.46 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count bottles). This firm fixed-price delivery order, with completion scheduled for December 3, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a $6,949.42 delivery order to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) on October 24, 2025, with an ultimate completion date of October 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price terms and is classified as a delivery order, indicating it is issued against a larger indefinite delivery vehicle. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a 90-count quantity, with a ceiling value of $1,867.39. This firm fixed-price delivery order has an ultimate completion date of October 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) at a ceiling value of $13,135.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract has an ultimate completion date of December 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a quantity of 90 units, with a contract ceiling value of $8,240.22. This firm fixed price delivery order represents a non-competitive award under an existing Indefinite Delivery Contract (IDC) and is scheduled for completion by December 9, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,704.97 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) on September 10, 2025, with completion scheduled for September 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $4,560.68 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count units) on October 31, 2025, with an ultimate completion date of November 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXPF4Delivery Order
The Defense Logistics Agency awarded a $13,934.26 delivery order to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (1,000 count) under a firm fixed-price contract. The award, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, carries no set-aside designation, indicating the contract was competitively awarded. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen, as a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills such orders for generic and brand-name medications across multiple therapeutic domains through this framework agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 12/4/25 |